Forecasts data is unavailable for this security.
Consensus recommendation
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Cadrenal Therapeutics Inc have a median target of 32.00, with a high estimate of 45.00 and a low estimate of 30.00. The median estimate represents a 93.24% increase from the last price of 16.56.
High | 171.7% | 45.00 |
Med | 93.2% | 32.00 |
Low | 81.2% | 30.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 14, 2025.
Average growth rate | -48.96% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
More ▼